Emmes

Executive Summary

Emmes is a full-service clinical research organization (CRO) that leverages technology and AI across all clinical functions to accelerate drug development for biopharmaceutical, government, non-profit, and academic partners. Founded in 1977 and headquartered in Rockville, Maryland, Emmes has established itself as a trusted partner in delivering high-quality, efficient programs. The company emphasizes end-to-end use of AI and digital tools to reduce timelines and improve outcomes, positioning itself at the forefront of innovation in clinical research. As a private entity, Emmes does not disclose financials, but its long-standing presence and focus on technology-driven solutions make it a key player in the CRO landscape.

Upcoming Catalysts (preview)

• Q3 2026Announcement of major AI-powered platform enhancement or partnership70% success
• H2 2026New multi-year contract with a top biopharma or government agency60% success
• 2027Expansion into new therapeutic areas such as gene therapy or rare diseases50% success